Supernus Pharmaceuticals (SUPN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist

30.260
+0.310+1.04%

Close Apr 24 16:00 ET

30.260
0.0000.00%

Post 16:02 ET

1.66BMarket Cap1513.00P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous
GlobeNewswire16:05 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)
TipRanksApr 15 07:10 ET
Supernus Pharmaceuticals Shares Slip 6.9% After FDA Says Drug Application Not Ready
By Ben Glickman Shares of Supernus Pharmaceuticals dropped Monday after regulators determined the company's new drug application was not ready for approval. The stock was down 6.9% to $31.23 in afte
WSJApr 8 13:49 ET
Supernus' Investigational Drug Application for Parkinson's Apomorphine Pump Suffers FDA Setback; Shares Fall Premarket
Supernus Pharmaceuticals (SUPN) said Monday the Federal Drug Administration had issued a Complete Response Letter in response to its new drug application for SPN-830, a setback for the investigational
MT NewswiresApr 8 09:17 ET
Supernus Stock Slides as FDA Rejects Parkinson's Disease Infusion Device
Seeking AlphaApr 8 08:39 ET
Express News | Supernus Pharmaceuticals Shares Are Trading Lower After the Company Announced the FDA Has Issued a Complete Response Letter in Response to the Company's New Drug Application for SPN-830
Moomoo 24/7Apr 8 08:20 ET

Comments

Meltyy

Apr 9 23:48

FDA PDUFA Update…

🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US)$ & $Johnson & Johnson(JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US)$ & $Bristol-Myers Squibb(BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US)$...

rocketeer

Apr 5 14:53

$Supernus Pharmaceuticals(SUPN.US)$ so many insider selling non stop. hmmm

isaiahlilo

Apr 4 22:37

$Supernus Pharmaceuticals(SUPN.US)$
waiting patiently for fda 😌🙏

Meltyy

Apr 2 10:41

FDA PDUFA Update…

🗓️ Last week’s PDUFAs:
$Akebia Therapeutics(AKBA.US)$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co(MRK.US)$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca(AZN.US)$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals(REGN.US)$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca(AZN.US)$ : 🤔
⇒...